Indian-origin UCLA researcher awarded $3.5 million NIH grant to study mpox virus

Dr. Arumugaswami’s team is especially focused on creating antiviral drugs, which he said are “another essential tool, for people already infected”.

Microscopy image and Dr. Vaithilingaraja Arumugaswami / UCLA

A UCLA-led team led by Indian-origin researcher Dr. Vaithilingaraja Arumugaswami has been awarded a $3.5 million grant from the National Institutes of Health (NIH) to advance treatment and understanding of mpox, a viral disease formerly known as monkeypox. The five-year grant was announced on July 2 by the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

Arumugaswami, who is originally from Tamil Nadu, is a professor of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA. The research team also includes co-principal investigator Dr. Ashok Kumar of Wayne State University and UCLA’s Dr. Robert Damoiseaux, director of the Molecular Screening Shared Resource.

This post is for paying subscribers only

SUBSCRIBE NOW

Comments

This is a Premium Article, available exclusively to our subscribers.

Read 500+ such News or articles every month by subscribing today!
Monthly

Free

Limited Access

Limited View

Free weekly E-Paper

Subscribe Now
Monthly

$10

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Annual

$50

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Start the conversation

Become a member of New India Abroad to start commenting.

Sign Up Now

Already have an account? Login